The Convergence of AI and Real-World Data are Reshaping Clinical Trials
As clinical trials increase in number and complexity, so does the competition for the patients best aligned to the study requirements. And with clinical trial processes relatively unchanged over the past decades, a patient and investigator bottleneck has emerged. Finally, with the convergence of artificial intelligence and algorithms trained on real-world data (RWD) sources, we […]
Inside Norstella’s Innovation Engine: How the Next Generation of Real-World Data Gets You Closer to the Patient
Real-world data (RWD) is transforming the life sciences industry, giving pharma companies valuable insights into the patient journey and helping more people get the life-saving treatments they need. To discuss the power of real-world data, where it’s headed, and how it’s fueling Norstella’s next generation of product development, we caught up with Kris Kaneta, Chief […]
Real-World Data, Real-World Impact
This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance Wolkenbrod discussing how integrated real-world data (RWD) is improving patient access to therapies in multiple myeloma. By combining claims, EMR, lab, mortality, and physician note data, Norstella developed clinical profiles that helped identify patients at key disease stages and match […]
Ultimate Real-World Data Showdown
This episode of “Real-World Data After Dark” features Daniel Chancellor, Dr. Madeline Naylor, and Lance discussing how real-world data (RWD), EMR data, and AI are transforming pharma decision-making and patient care. Through a game-show-style conversation, they explore how integrated datasets and unstructured clinical data help generate real-world evidence, improve patient identification, accelerate therapies to market, […]
Real-World Data Revealed: Getting to Know Our Experts
Real-World Data After Dark is a Norstella mini-series that blends late-night talk show energy with expert conversations on real-world data (RWD) and its importance to the pharmaceutical industry, hosted by Daniel Chancellor, VP of Thought Leadership at Norstella. In this inaugural episode, chief clinician Dr. Madeline Naylor and senior principal of RWD Solutions Lance Wolkenbrod […]
Real-World Data in 2025 and Beyond: Closing the Strategy Gap
Pharma leaders agree that real-world data (RWD) is essential—but many still struggle to harness its full potential. In Real-World Data in 2025 and Beyond: Closing the Strategy Gap, Norstella surveyed 200 life sciences executives to uncover how organizations are using RWD, where they’re falling short, and what separates high-performing strategies from the rest. The findings […]
Real-World Data in 2025 and Beyond: Closing the Strategy Gap
Real-world data has already proven its power to transform patient outcomes, accelerate clinical development, and strengthen commercial strategies, but its full value is realized only when pharma organizations approach it with a cohesive, forward-looking strategy. Our white paper, Real-world data in 2025 and beyond: Closing the strategy gap, surveyed 200 life sciences executives to gather […]
The ROI of Real-World Data: Understanding the Current and Future State of RWD
From clinical trials to regulatory submissions to HEOR research, the value of real-world data (RWD) is clear. So how are today’s pharma leaders using RWD in commercialization strategies, and where are the gaps in realizing its full potential? This infographic reveals the results of Norstella’s survey of 200 life sciences executives about their use of […]
LinQ Cohort: Accelerate Feasibility, Targeting, and Planning
Finding the right patients and HCPs should be fast, but today’s cohorting process slows progress across the lifecycle. This infographic explores how LinQ Cohort, powered by NorstellaLinQ’s linked, tokenized real-world data, helps you: Instantly find and size precise patient populations. Search across structured and unstructured data — EMR, labs, claims, and notes. Explore feasibility, design […]
Pharma’s Real-World Data Dilemma: Strategic Asset or Wasted Resource?
Every day, patients are experiencing the life-changing impact of real-world data (RWD), and life sciences companies are feeling the business impact, too. RWD is no doubt helping pharma companies better understand the patient journey and get life-saving therapies to market faster, according to Norstella’s recent survey of 200 life science executives. Over the next one […]
